Parecer de pré-exame
#6.23
05/09/2023
RPI 2731
Application data
Number
112020026202Type
Filing
Publication
PCT
JP2019025512 The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.
Latest action published by the INPI: 05/09/2023. We update with every new RPI gazette, published weekly.
Applicants
MEIJI SEIKA PHARMA CO., LTD.
JP
Inventors
K. T. (pessoa física)
JP
K. K. (pessoa física)
JP
M. T. (pessoa física)
JP
T. W. (pessoa física)
JP
IPC Classification
Priority claims
JP
2018-121413 · 06/27/2018
Abstract
CRISTAL DE DERIVADO DE BENZOXAZOL.São fornecidos cristais de 1 - ((2- (3,6-diazabiciclo [3.1.1] heptan-3-il)-7-(tiazol-2-il) benzo [d] oxazol-4-il) oxi)-1,1-difluor-2-metilpropan-2-ol, representado pela fórmula (1).
Publications in the Brazilian Industrial Property Gazette (RPI).
#6.23
05/09/2023
RPI 2731
#1.3
03/23/2021
RPI 2620
#1.1
01/05/2021
RPI 2609
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.